Combined role of transrectal ultrasonography, gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer
- 31 August 1993
- Vol. 42 (2), 130-137
- https://doi.org/10.1016/0090-4295(93)90635-n
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992
- Preoperative Prediction of Pathological Tumor Volume and Stage in Clinically Localized Prostate Cancer: Comparison of Digital Rectal Examination, Transrectal Ultrasonography and Magnetic Resonance ImagingJournal of Urology, 1991
- Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate CancerNew England Journal of Medicine, 1990
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990
- Sonographic and Pathological Staging of Patients with Clinically Localized Prostate CancerJournal of Urology, 1989
- Staging of Prostate CancerUrologic Clinics of North America, 1989
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Prostate-specific antigen in management of prostatic carcinomaUrology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989